BMX — BioMaxima SA Income Statement
0.000.00%
Last trade - 00:00
- PLN66.67m
- PLN74.32m
- PLN145.51m
- 84
- 34
- 29
- 45
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | PAS | PAS | PAS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 30.8 | 30.5 | 61.6 | 81.1 | 146 |
Cost of Revenue | |||||
Gross Profit | 13.3 | 13 | 23.9 | 32.1 | 57.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 31.1 | 29.9 | 52.2 | 68.1 | 111 |
Operating Profit | -0.302 | 0.629 | 9.4 | 13 | 34.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.532 | 0.182 | 8.75 | 12.8 | 35.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.462 | 0.014 | 7.33 | 10.2 | 28.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.482 | -0.014 | 7.36 | 10.2 | 28.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.482 | -0.014 | 7.36 | 10.2 | 28.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.068 | 0.026 | 1.8 | 2.41 | 6.48 |
Dividends per Share |